RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
Thromb Haemost 1998; 80(03): 530
DOI: 10.1055/s-0037-1615249
DOI: 10.1055/s-0037-1615249
Letters to the Editor
Fatal Danaparoid-sodium Induced Thrombocytopenia and Arterial Thromboses
Weitere Informationen
Publikationsverlauf
Received
19. März 1998
Accepted after revision
07. Mai 1998
Publikationsdatum:
08. Dezember 2017 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/199803/lookinside/thumbnails/10-1055-s-0037-1615249-1.jpg)
-
References
- 1 Magnani HN. Heparin-induced thrombocytopenia: an overview of 230 patients treated with danaparoid-sodium (Org 10172). Thromb Haemost 1993; 70: 554-61.
- 2 Tardy-Poncet B. French experience in the use of danaparoid-sodium as an alternative antithrombotic treatment for patients with heparin induced thrombocytopenia. Thromb Haemost 1998 (Suppl) 1825a.
- 3 Warkentin TE. Danaparoid (Danaparoid-sodium) for the treatment of heparin-induced thrombocytopenia (HIT) and thrombosis: effects on in vivo thrombin and cross-linked fibrin significance of in vitro cross-reactivity of danaparoid for HIT-IgG. Blood 1996; 88 (Suppl. 01) 626a.